Trial · NCT01764854
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | diarrhea | Gastrointestinal disorders | AZD1722- in Patient | 6 | 8 | 6 |
| other | diarrhea | Gastrointestinal disorders | Placebo- in Patient | 2 | 8 | 2 |
| other | diarrhea | Gastrointestinal disorders | AZD1722 Out-patient | 3 | 37 | 3 |
| other | diarrhea | Gastrointestinal disorders | Placebo Out-patient | 21 | 35 | 21 |
| serious | Syncope | Cardiac disorders | AZD1722- in Patient | 0 | 8 | 0 |
| serious | Syncope | Cardiac disorders | Placebo- in Patient | 1 | 8 | 1 |
| serious | Syncope | Cardiac disorders | AZD1722 Out-patient | 1 | 37 | 1 |
| serious | Syncope | Cardiac disorders | Placebo Out-patient | 0 | 35 | 0 |
| serious | Urinary Tract Infection | Renal and urinary disorders | AZD1722- in Patient | 0 | 8 | 0 |
| serious | Urinary Tract Infection | Renal and urinary disorders | Placebo- in Patient | 0 | 8 | 0 |
| serious | Urinary Tract Infection | Renal and urinary disorders | AZD1722 Out-patient | 1 | 37 | 1 |
| serious | Urinary Tract Infection | Renal and urinary disorders | Placebo Out-patient | 0 | 35 | 0 |
| serious | acute respiratory failure | Respiratory, thoracic and mediastinal disorders | AZD1722- in Patient | 0 | 8 | 0 |
| serious | acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo- in Patient | 1 | 8 | 1 |
| serious | acute respiratory failure | Respiratory, thoracic and mediastinal disorders | AZD1722 Out-patient | 0 | 37 | 0 |
| serious | acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo Out-patient | 0 | 35 | 0 |
| serious | local swelling | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD1722- in Patient | 0 | 8 | 0 |
| serious | local swelling | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo- in Patient | 1 | 8 | 1 |
| serious | local swelling | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD1722 Out-patient | 0 | 37 | 0 |
| serious | local swelling | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo Out-patient | 0 | 35 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01764854/events